[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lipaemia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lipaemia":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":36,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":5},"100589205","the-impact-of-daily-intake-of-short-chain-fatty-acids-on-cardiometabolic-risk-factors-in-individuals-at-risk-for-metabolic-syndrome-100589205",false,"NCT06951386","The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome","The Impact of 12 Weeks Intervention With Plant-based Oat Drink Rich in Short-chain Fatty Acids on Postprandial Lipidemia in Individuals at Risk for Metabolic Syndrome","12OATS","Inclusion Criteria:\n\n* male and female participants\n* central obesity ( BMI ≥ 25 kg\u002Fm² or waist circumference ≥ 80 cm for women\u002F ≥ 94 cm for men)\n* One additional risk factor for metabolic syndrome:\n\n  1. Insulin resistance (HOMA-IR ≥ 1.7 or fasting glucose ≥ 100 mg\u002Fdl)\n  2. Triglyceride concentration ≥ 150 mg\u002Fdl\n  3. HDL-cholesterol \\\u003C 40 mg\u002Fdl for women\u002F \\\u003C 50 mg\u002Fdl for men\n  4. Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg\n* knowledge of English\n\nExclusion Criteria:\n\n* gastrointestinal disorders such as IBD, IBS, celiac disease, chronic constipation, chronic diarrhoea\n* history of abdominal surgery, except for appendectomy\n* Use of antihypertensive, cholesterol lowering, glucose-regulating drugs and corticosteroids\n* Use of antibiotics 3 months prior to the start or during the study\n* Use of probiotics and prebiotics 2 weeks prior to the start of the study\u002F during the study\n* Being on weight loss, gluten-free, lactose-free or vegan diet\n* Pregnancy, lactation or wish to become pregnant\n* Previous or current substance\u002F alcohol dependence or abuse\n* Hyper- or hypothyroidism\n* Allergy or intolerance to oat milk","ALL","18 Years","65 Years",{"count":21,"type":22},50,"ESTIMATED","INTERVENTIONAL",[25],"NA","During this study, the effect of short-chain fatty acids on blood lipaedemia, glycemia, anthropometrics, blood pressure and energy expenditure will be investigated.",[28,29,30,31,32,33,34,35],"Energy Expenditure","Metabolic Syndrome","Anthropometry","Body Composition","Glycemia","Lipaemia","Metabolomics","Blood Pressure",[37,38],"short-chain fatty acids","cardiometabolic health","RECRUITING","2025-04-30",{"date":42,"type":43},"2025-05-04","ACTUAL",{"date":45,"type":43},"2025-02-11",{"date":47,"type":22},"2026-02-28",{"name":49,"class":50},"KU Leuven","OTHER"]